Literature DB >> 11772942

Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium.

Arumugam Muruganandam1, Jamshid Tanha, Saran Narang, Danica Stanimirovic.   

Abstract

Delivery to the brain of drugs, peptides, and genes depends on the availability of brain-specific delivery vectors. We used a phage-displayed library of llama single-domain antibodies (sdAbs) to enrich for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). Two sdAbs (FC5 and FC44) were selected, sequenced, subcloned, and expressed as fusion proteins with c-Myc-His5 tags. Similar to phage-displayed sdAbs, soluble FC5 and FC44 were shown to selectively bind HCEC and to transmigrate across an in vitro human blood-brain barrier (BBB) model. Both FC5 and FC44, in contrast to an unrelated llama sdAb, were also detected in the brain after i.v. injection into mice. These small (approximately 14 kDa) antibodies have characteristics essential for a carrier-vector and can be used to facilitate drug transport across the BBB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11772942     DOI: 10.1096/fj.01-0343fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  65 in total

Review 1.  Targeting gene therapy vectors to the vascular endothelium.

Authors:  Lorraine M Work; Stuart A Nicklin; Andrew H Baker
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

2.  Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.

Authors:  Ana Maria Gonzalez; Wendy Leadbeater; Sonia Podvin; Alexandra Borboa; Michael Burg; Ritsuko Sawada; James Rayner; Karen Sims; Tetsuya Terasaki; Conrad Johanson; Edward Stopa; Brian Eliceiri; Andrew Baird
Journal:  Brain Res       Date:  2010-08-21       Impact factor: 3.252

3.  A yeast display immunoprecipitation screen for targeted discovery of antibodies against membrane protein complexes.

Authors:  Jason M Lajoie; Yong Ku Cho; Dustin Frost; Samantha Bremner; Lingjun Li; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

Review 4.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Mining a yeast library for brain endothelial cell-binding antibodies.

Authors:  Xin Xiang Wang; Yong Ku Cho; Eric V Shusta
Journal:  Nat Methods       Date:  2007-01-07       Impact factor: 28.547

6.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

Review 7.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

8.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

9.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

10.  Differential recognition of vascular and parenchymal beta amyloid deposition.

Authors:  Kim S Rutgers; Alexandra van Remoortere; Mark A van Buchem; C Theo Verrips; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch; Sjoerd G van Duinen; Marion L Maat-Schieman; Silvère M van der Maarel
Journal:  Neurobiol Aging       Date:  2009-12-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.